References
Baquet CR, Commiskey P, Mullins CD, Mishra SI. Recruitment and participation in clinical trials: sociodemographic, rural/urban, and health care access predictors.Cancer Detect Prev. 2006; 30:24–33.
Corbie-Smith G, Miller WC, Ransohoff, DF. Interpretations of ‘appropriate’ minority inclusion in clinical research.Am J Med. 2004; 116:249–52.
Swanson GM, Bailar JC. Selection and description of cancer clinical trials participants — science or happenstance?Cancer. 2002; 95:950–959.
Janson SL, Alioto ME, Boushey HA. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial.Controlled Clinical Trials. 2001;6:S236-S243.
Brandon, DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care?J Natl Med Assoc. 2005; 97:951–956.
Seto, B. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research.Am J Med Sci. 2001;322:246–50.
Comis RL, Aldige CR, Stovall EL, Krebs LU, Risher PJ, Taylor HJ. Public attitudes toward participation in cancer clinical trials.J Clin Oncol. 2003:5:830–835.
National Cancer Institute. Cancer Clinical Trials: The Basic Workbook. Available from: http://www.cancer.gov/clinicaltrials/resources/basicworkbook. Accessed November 18, 2009.
Nguyen TT, Somkin CP, Ma Y. Participation of Asian-American women in cancer chemoprevention research: physician perspectives.Cancer. 2005; 104:3006–14.
Killien M, Bigby JA, Champion V, et al. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women’s Health.J Womens Health Gend Based Med. 2000; 9:1061–70.
Ross S, Grant A, Counsell C, et al. Barriers to participation in randomized controlled trials: a systematic review.J Clin Epidemiol. 1999; 52:1143–56.
Goldman DP, Berry SH, McCabe MS, et al. Incremental treatment costs in National Cancer Institute-sponsored clinical trials.JAMA. 2003;289:2970–2977.
Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers.J Clin Oncol. 2004; 22:730–734.
Gross CP, Herrin J, Wong N, Krumholz HM. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics.J Clin Oncol. 2005; 23:4755–4763.
Crosson, K, Eisner E, Brown C, Ter Maat J. Primary care physicians’ attitudes, knowledge, and practices related to cancer clinical trials.J Cancer Educ. 2001;16:188–192.
Howerton MW, Gibbons MC, Baffi CR, et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials.Cancer. 2007;109: 465–476.
Hudson SV, Momperousse D, Leventhal H. Physician perspectives on cancer clinical trials and barriers to minority recruitment.Cancer Control. 2005; 12:93–6.
Getz KA. Racial disparities among clinical research investigators.Am J Ther. 2008;15: 319.
Ford JG, Howerton MW, Bolen S, et al. Knowledge and Access to Information on Recruitment of Underrepresented Populations to Cancer Clinical Trials. Evidence Report: Technology Assessment No.122, AHRQ Publication No. 05-E019-2. Rockville, MD. Agency for Healthcare Research and Quality. June 2005.
Geller EG, Goldstein M, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.Journal of Women’s Health. 2006;15:1123–1131.
Fouad MN, Partridge E, Green BL, Wynn T, Nagy S, Churchill S. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community.Ann Epidemiol. 2000; 10: S35–40.
Increasing minority participation in clinical research: a white paper from the Endocrine Society. December 2007. Available from: http://www.endo-society.org/advocacy/health_disparities/index.cfm# Accessed November, 18, 2009.
Noah, BA. The participation of underrepresented populations in clinical research.J Law Med Med. 2003:29:221–224.
Rdesinski RE, Melnick AL, Creach ED, Cozzens J, Carney PA. The cost of recruitment and retention of women from community-based programs into a randomized controlled contraceptive study.J Health Care Poor Underserved. 2008;19:639–51.
Author information
Authors and Affiliations
Corresponding author
Additional information
The EDICT project is funded by an unrestricted educational grant from Genentech, Inc.
Rights and permissions
About this article
Cite this article
Spiker, C.A., Weinberg, A.D. Policies to address disparities in clinical trials: The EDICT project. J Canc Educ 24 (Suppl 2), S39–S49 (2009). https://doi.org/10.1007/BF03182311
Issue Date:
DOI: https://doi.org/10.1007/BF03182311